文章核心观点 - 该文章报道了2024年度Altair Enlighten Award获奖名单,这是一个专注于汽车行业可持续性和轻量化创新的重要奖项 [1][2][4][5][6] - 获奖企业包括杜邦、宝马、陶氏、丰田、通用等行业领先企业,他们在减碳、节能、材料再利用等方面取得了重大突破 [3][7][10][13][17][23][27] - 获奖技术涵盖了可持续产品、可持续生产工艺、模块轻量化、关键使能技术等多个领域,体现了行业在可持续发展方面的不同创新 [7][10][13][17][23] 可持续产品 - 杜邦的BETAMATE广谱固化粘接技术可以在较低温度下固化,从而减少车身制造过程中的能耗和温室气体排放 [7][8] - 普利司通的Turanza EV轮胎采用50%可再生和回收材料制造,并采用ENLITEN技术优化性能和延长使用寿命 [8][9] 可持续生产工艺 - 宝马M公司等企业开发了基于循环设计理念和可再生材料的BMW M Visionary Materials座椅 [10][11] - 丰田和PPG开发的EPIC200X电泳涂料可以大幅减少CO2排放、能耗和用水量 [11][12] 模块轻量化 - 赛恩斯科和通用汽车开发了一种高性能热塑性电池模块结构,相比铝材可减重37%、降低25%成本 [13][14] - 丰田等企业开发了30%更轻的塑料复合材料二排座椅结构 [15][16] 关键使能技术 - 康波特公司利用天然纤维复合材料开发了可用于车身、内饰等多种汽车部件的可持续高性能结构 [17][18] - 帝人公司开发了全自动预成型工艺,可大幅提高碳纤维预制件的生产效率 [19][20] 未来轻量化 - WEAV3D等企业开发了一种成本更低、重量更轻的复合材料车身结构 [23][24][25] - 卡索利亚公司开发了50%更轻的碳纤维复合材料悬架弹簧 [25][26] 负责任的人工智能 - 陶氏公司开发了一种基于人工智能的可持续聚氨酯解决方案,大幅降低了有害物质排放 [27][28]

PLANO, Texas, Aug. 6, 2024 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) today announced a landmark collaboration with NRTC, Southern Linc, and Anterix (NASDAQ: ATEX) to deliver cutting-edge private network solutions to electric cooperatives (co-ops) of all sizes and service terrains across the United States. This strategic partnership aims to provide reliable, resilient, and secure network infrastructure, empowering co-ops to meet the challenges of modernizing the grid infrastructure and ensuring uninterrupted s ...

SOMERSET, N.J., Aug. 06, 2024 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the "Company") (NASDAQ:CCLD, CCLDO, CCLDP))), a leader in healthcare technology solutions for medical practices and health systems nationwide, today announced the continuation of proxy solicitation from the holders (the "Series A Preferred Shareholders") of its 11% Series A Cumulative Redeemable Perpetual Preferred Stock (the "Series A Preferred Stock") to approve an amendment to the Company's Certificate of Designations, Preferences and Rig ...

-- Closed $12.5 million private placement financing led by SR One with participation from ADAR1 Capital Management and another life sciences-focused investor – -- Cash resources of $54.2 million as of June 30, 2024, together with anticipated funding remaining from CIRM award, expected to fund operations into 4Q 2025 – -- Topline data from Phase 2b CHASE trial of KPI-012 for PCED targeted in Q1 2025 -- ARLINGTON, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharm ...

CASTLE ROCK, Colo, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Where Food Comes From, Inc. (WFCF) (NASDAQ:WFCF), the most trusted resource for independent, third-party verification of food production practices in North America, today announced it will release its 2024 second quarter financial results before the market opens on Thursday, August 8, 2024, and conduct a conference call the same day at 10:00 a.m. Mountain Time (12:00 p.m. Eastern). Dial-in numbers for the conference call: Domestic Toll Free: 1-877-407-82 ...

Early results of a novel weed management solution using two herbicides show promise. The first known use of stacked gene edited herbicide tolerant traits in an elite variety of rice to improve weed management. SAN DIEGO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that it has positive initial field trial results of a novel weed management solution for rice farm ...

SYDNEY, Aug. 06, 2024 (GLOBE NEWSWIRE) -- IREN (NASDAQ:IREN) (together with its subsidiaries, "IREN" or "the Company"), a leading next-generation data center business powering the future of Bitcoin, AI and beyond, today published a monthly investor update for July 2024. Key Highlights Bitcoin MiningAI Cloud Services 222 Bitcoin mined in July10.5 EH/s installed (as of Aug 5)20 EH/s in 3Q, 30 EH/s in 4Q 816 NVIDIA H100 GPUsServicing multiple reserved/on-demand customers Data CentersCorporate 260MW operating, ...

BURLINGTON, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported business updates and financial results for the second quarter of 2024 ending June 30, 2024. Roluperidone NDA Update During the first quarter of this year, the Company announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) to ...

- Promising Phase 1/2 SNS-101 clinical data presented at ASCO 2024 - - Enrollment in the Phase 1 dose expansion of SNS-101 clinical trial advancing with initial data on track for Q4 2024 - - Strong balance sheet with cash runway into the fourth quarter of 2025 - BOSTON, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today reported financial re ...

FOX REPORTS FULL YEAR FISCAL 2024 REVENUES OF $13.98 BILLION, NET INCOME OF $1.55 BILLION, AND ADJUSTED EBITDA OF $2.88 BILLION NEW YORK, Aug. 6, 2024 /PRNewswire/ -- Fox Corporation (Nasdaq: FOXA, FOX; "FOX" or the "Company") today reported financial results for the three and twelve months ended June 30, 2024. Commenting on the results, Executive Chair and Chief Executive Officer Lachlan Murdoch said: "Fiscal 2024 was another successful year for FOX with very clear achievements across our portfolio, includ ...